Rx.Health, the digital medicine company, has teamed up with Wise Therapeutics to deliver a game-based digital therapeutic (DTx) for people with anxiety.
Rx.Health explained that the DTx will be made available through its own health plan and those operated by other health systems. Its services have expanded rapidly over the last few years to include digital monitoring and prescribing, virtual healthcare, and real-world registry enrolment.
Wise develops game-based mobile apps using its Personal Zen platform, which relies on a form of cognitive behavioural therapy (CBT) known as attention bias modification (ABM). It is designed to modify the way the attention of a person with anxiety is directed to negative stimuli in the environment, which can become exaggerated and overwhelming, and direct them towards stimuli associated with positive feelings.
Wise is also working on different versions of the software that will be developed as prescription DTx, with the objective of securing FDA approvals.
Wise’s Personal Zen app has already been shown to reduce feelings of anxiety and negative mood in children and adolescents with multiple sclerosis in a pilot study published in the journal Frontiers in Neurology.
Through the Rx.Health platform, which is embedded in the electronic health record (EHR), physicians will be able to “prescribe, monitor, educate, and onboard patients” who are candidates for the DTx. Clinicians will also be able to take advantage of its new remote therapeutic monitoring codes, which reimburse them for educating, onboarding, and monitoring patient adherence to digital treatment programmes.
Join the HealthXL Webinar on ‘Retail Healthcare: Current and Future Opportunities for Digital Health’ on 26th January. Click here to Request to Join.
Click here to read the original news story.